Search research articles
Contact Us
Filters
Showing results (101-110 of 104) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 104 results.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
April 19, 2025
Effect of host-protein test (TRAIL/IP-10/CRP) on antibiotic prescription and emergency department or urgent care center return visits: The JUNO pilot randomized controlled trial
Adam J Singer, Judd E Hollander, Efrat R Kean, et al.
Heart Rhythm
|
June 1, 2005
Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one
Sami Viskin, Uri Rosovski, Andrew J Sands, et al.
Vaccine
|
October 17, 2025
Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults
Yoseph Caraco, Noa Madar-Balakirski, Eytan Ben-Ami, et al.
JAMA
|
January 10, 2022
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel
Avishay Spitzer, Yoel Angel, Or Marudi, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 104) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 104 results.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
April 19, 2025
Effect of host-protein test (TRAIL/IP-10/CRP) on antibiotic prescription and emergency department or urgent care center return visits: The JUNO pilot randomized controlled trial
Adam J Singer, Judd E Hollander, Efrat R Kean, et al.
Heart Rhythm
|
June 1, 2005
Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one
Sami Viskin, Uri Rosovski, Andrew J Sands, et al.
Vaccine
|
October 17, 2025
Using the vesicular stomatitis virus vector (rVSV vector) platform for SARS-CoV-2 vaccine development: Phase 1/2 safety and immunogenicity of IIBR-100 in healthy adults
Yoseph Caraco, Noa Madar-Balakirski, Eytan Ben-Ami, et al.
JAMA
|
January 10, 2022
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel
Avishay Spitzer, Yoel Angel, Or Marudi, et al.
Page
of 11